Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by DigitalSpurson Apr 16, 2020 12:27pm
139 Views
Post# 30916915

Cascade Chemists and AGN (Excellent firm!!)

Cascade Chemists and AGN (Excellent firm!!)From the article yesterday,

https://ca.proactiveinvestors.com/companies/news/917329/algernon-pharmaceuticals-gets-fda-thumbs-up-on-new-intravenous-version-of-ifenprodil-917329.html


Some may have skipped the due dilligence part on what company is assisting AGN in synthesizing the drug for IV tests, also mention in a previous release.

The article states:

"Work has already begun on the synthesis of the intravenous drug by Cascade Chemistry, who have identified a potentially novel and proprietary synthetic route to the final product."


Cascade Chemisty has been in business for nearly 40 YEARS!!

Linkedin page: https://www.linkedin.com/company/organic-consultants-inc-/


FINALLY and MOST IMPROTANTLY - AGN didn't go to a small mom and pop shop to get some NR out so they can pump this stock up. They are in it for REAL and they are CONFIDENT in their product. THis is why they hired a reputable firm to get this done.

Their team consists of almost 90% PHD level chemists and a large team to get this done.

Check out their team page here and wealth of experience to get AGN to the next level and FAST:

https://cascadechemistry.com/our-people/
Bullboard Posts